Munoz-Perez, E.; Gonzalez-Pujana, A.; Igartua, M.; Santos-Vizcaino, E.; Hernandez, R.M.
Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues. Pharmaceutics 2021, 13, 1802.
https://doi.org/10.3390/pharmaceutics13111802
AMA Style
Munoz-Perez E, Gonzalez-Pujana A, Igartua M, Santos-Vizcaino E, Hernandez RM.
Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues. Pharmaceutics. 2021; 13(11):1802.
https://doi.org/10.3390/pharmaceutics13111802
Chicago/Turabian Style
Munoz-Perez, Elena, Ainhoa Gonzalez-Pujana, Manoli Igartua, Edorta Santos-Vizcaino, and Rosa Maria Hernandez.
2021. "Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues" Pharmaceutics 13, no. 11: 1802.
https://doi.org/10.3390/pharmaceutics13111802
APA Style
Munoz-Perez, E., Gonzalez-Pujana, A., Igartua, M., Santos-Vizcaino, E., & Hernandez, R. M.
(2021). Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues. Pharmaceutics, 13(11), 1802.
https://doi.org/10.3390/pharmaceutics13111802